Framing the Problem: The Mystery of Post-Finasteride Syndrome and Reasons to Suspect a Microbial Factor

This paper proposes a novel hypothesis for Post-Finasteride Syndrome (PFS), suggesting that gut dysbiosis acts as a crucial "third factor" in the condition's development. While PFS is often linked to epigenetic silencing of the androgen receptor, this does not fully explain non-androgenic symptoms like chronic fatigue and cognitive impairment, nor the fluctuating "recovery-to-crash" cycles. The paper argues that dysbiosis, potentially triggered by Finasteride, could lead to excessive beta-glucuronidase production, affecting hormone elimination and causing compensatory epigenetic changes. Additionally, toxic by-products from dysbiotic microbes may directly cause non-androgenic symptoms. This microbiome-mediated perspective offers a comprehensive explanation for PFS's persistence and symptom variability.